Some diabetes drugs like liraglutide and semaglutide might help protect knee cartilage by calming inflammation in lab and animal studies — could this mean they help with arthritis?

1

Pro

0

Against

Evidence from Studies

Supporting (1)

1

Community contributions welcome

1

The Role of GLP-1 Receptor Agonists In Rheumatic Diseases and Osteoarthritis: A Literature Review

Narrative Review

Animal

The study looks at the same drugs mentioned in the claim and finds they help protect cartilage in lab and animal studies by reducing inflammation and cell damage, just like the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

The Role of GLP-1 Receptor Agonists In Rheumatic Diseases and Osteoarthritis: A Literature Review

Score: 1

DOI: 10.52338/tjocm.2025.5014

Similar Assertions

Some diabetes drugs called GLP-1RAs might help protect knee cartilage from breaking down in early lab studies, and this has been seen with drugs like liraglutide, dulaglutide, and exenatide.

8

0

86%

Some diabetes drugs like liraglutide and exenatide might help protect cartilage in arthritic joints by slowing down the breakdown of important joint components.

26

0

84%

Some diabetes drugs might help calm joint inflammation and protect cartilage in animals with osteoarthritis, especially when given in higher doses.

8

0

83%

A type of diabetes drug might help protect joint cartilage in arthritis by stopping cells from leaking important building blocks.

12

0

82%

Some diabetes drugs called GLP-1 agonists might help calm down body-wide inflammation and reduce stress on cells, which could slow down joint damage in people with osteoarthritis.

1

0

80%